Effect of Acid Pump Antagonist (Revaprazan, Revanex®) on Result of13C Urea Breath Test in Patients withHelicobacter pyloriAssociated Peptic Ulcer Disease | Zendy

Ju Hyun Oak | Zendy; Woo Chul Chung | Zendy; Sung Hoon Jung | Zendy; Kang Hyun Choi | Zendy; EunJung Kim | Zendy; Bong Koo Kang | Zendy; Borami Kang | Zendy; Si Eun Kong | Zendy; Chang Nyol Paik | Zendy; KangMoon Lee | Zendy

Open Access

Effect of Acid Pump Antagonist (Revaprazan, Revanex®) on Result of13C Urea Breath Test in Patients withHelicobacter pyloriAssociated Peptic Ulcer Disease

Author(s) -

Ju Hyun Oak,

Woo Chul Chung,

Sung Hoon Jung,

Kang Hyun Choi,

EunJung Kim,

Bong Koo Kang,

Borami Kang,

Si Eun Kong,

Chang Nyol Paik,

KangMoon Lee

Publication year - 2011

Publication title -

korean journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.203

H-Index - 25

eISSN - 2233-6869

pISSN - 1598-9992

DOI - 10.4166/kjg.2011.57.1.8

Subject(s) - medicine , helicobacter pylori , urea breath test , gastroenterology , rapid urease test , proton pump inhibitor , peptic ulcer , breath test , disease , peptic , antacid , gastritis , helicobacter pylori infection

Revaprazan (Revanex(R)) is a novel proton pump inhibitor (PPI) that has a somewhat different effect on proton pump compared with the other PPI's, also (called as 'acid pump antagonist'). We aimed to examine the false negative rate of 13C-urea breath test (UBT) in the patients with Helicobacter pylori (H. pylori) associated peptic ulcer disease who were treated with revaprazan and evaluate the anti-urease activity of revaprazan.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research